The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Background The poor physical health of people with mental illness is a multifaceted,
transdiagnostic, and global problem. People with mental illness have an increased risk of …
transdiagnostic, and global problem. People with mental illness have an increased risk of …
Pragmatic trials
I Ford, J Norrie - New England journal of medicine, 2016 - Mass Medical Soc
In pragmatic trials, participants are broadly representative of people who will receive a
treatment or diagnostic strategy, and the outcomes affect day-to-day care. The authors …
treatment or diagnostic strategy, and the outcomes affect day-to-day care. The authors …
Long-term evolocumab in patients with established atherosclerotic cardiovascular disease
ML O'Donoghue, RP Giugliano, SD Wiviott, D Atar… - Circulation, 2022 - Am Heart Assoc
Background: In FOURIER (Further Cardiovascular Outcomes Research With PCSK9
Inhibition in Subjects With Elevated Risk), the proprotein convertase subtilisin-kexin type 9 …
Inhibition in Subjects With Elevated Risk), the proprotein convertase subtilisin-kexin type 9 …
[HTML][HTML] Coronary CT angiography and 5-year risk of myocardial infarction
SCOT-Heart Investigators - New England Journal of Medicine, 2018 - Mass Medical Soc
Background Although coronary computed tomographic angiography (CTA) improves
diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year …
diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year …
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
A Rawshani, N Sattar, S Franzén, A Rawshani… - The Lancet, 2018 - thelancet.com
Background People with type 1 diabetes are at elevated risk of mortality and cardiovascular
disease, yet current guidelines do not consider age of onset as an important risk stratifier …
disease, yet current guidelines do not consider age of onset as an important risk stratifier …
[HTML][HTML] Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised …
Methods The original intervention (mean treatment duration 7.8 years) involved 160 patients
with type 2 diabetes and microalbuminuria who were randomly assigned (using sealed …
with type 2 diabetes and microalbuminuria who were randomly assigned (using sealed …
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts… - European heart …, 2015 - academic.oup.com
Familial hypercholesterolaemia (FH) is a common genetic cause of premature coronary
heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and …
heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and …
[HTML][HTML] Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia-2019
DB Précoma, GMM Oliveira, AF Simão… - Arquivos Brasileiros …, 2019 - SciELO Brasil
Níveis de evidência Nível A Dados obtidos a partir de múltiplos estudos randomizados de
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …
bom porte, concordantes e/ou de meta-análise robusta de estudos clínicos randomizados …
[HTML][HTML] Statin therapy: review of safety and potential side effects
S Ramkumar, A Raghunath… - Acta cardiologica sinica, 2016 - ncbi.nlm.nih.gov
Background Hydroxymethyl glutaryl coenzyme A reductase inhibitors, commonly called
statins, are some of the most commonly prescribed medications worldwide. Evidence …
statins, are some of the most commonly prescribed medications worldwide. Evidence …
[HTML][HTML] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell… - Lancet (London …, 2012 - europepmc.org
Background Statins reduce LDL cholesterol and prevent vascular events, but their net effects
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …